Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 366

1.

Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.

Bautista D, Bermúdez-Silva FJ, Lasarte JJ, Rodriguez-Fonseca F, Baixeras E.

J Pathol. 2007 Nov;213(3):347-55.

PMID:
17940994
2.

Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A.

Duong FH, Filipowicz M, Tripodi M, La Monica N, Heim MH.

Gastroenterology. 2004 Jan;126(1):263-77.

PMID:
14699505
3.

Predictive value of the phosphorylation of signal transducers and activators of transcription in the outcome of interferon therapy for chronic hepatitis C.

Miyaaki H, Ichikawa T, Nakao K, Takeshita S, Shibata H, Ozawa E, Akiyama M, Miuma S, Eguchi K.

Intervirology. 2008;51(6):394-9. doi: 10.1159/000205264. Epub 2009 Mar 4.

PMID:
19258717
4.

The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapy.

El-Saadany S, Ziada DH, El Bassat H, Farrag W, El-Serogy H, Eid M, Abdallah M, Ghazy M, Salem HA.

Can J Gastroenterol. 2013 Feb;27(2):e13-7.

5.

Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies.

Larrea E, Aldabe R, Molano E, Fernandez-Rodriguez CM, Ametzazurra A, Civeira MP, Prieto J.

Gut. 2006 Aug;55(8):1188-96. Epub 2005 Aug 24.

6.

Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes.

Radaeva S, Jaruga B, Hong F, Kim WH, Fan S, Cai H, Strom S, Liu Y, El-Assal O, Gao B.

Gastroenterology. 2002 Apr;122(4):1020-34.

PMID:
11910354
7.

Hepatic metallothionein in patients with chronic hepatitis C: relationship with severity of liver disease and response to treatment.

Carrera G, Paternain JL, Carrere N, Folch J, Courtade-Saïdi M, Orfila C, Vinel JP, Alric L, Pipy B.

Am J Gastroenterol. 2003 May;98(5):1142-9.

PMID:
12809840
8.

Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs.

Melén K, Fagerlund R, Nyqvist M, Keskinen P, Julkunen I.

J Med Virol. 2004 Aug;73(4):536-47.

PMID:
15221897
9.

Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.

Abbate I, Romano M, Longo R, Cappiello G, Lo Iacono O, Di Marco V, Paparella C, Spano A, Capobianchi MR.

J Med Virol. 2003 Aug;70(4):581-7.

PMID:
12794720
12.

Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.

Murao K, Imachi H, Yu X, Cao WM, Nishiuchi T, Chen K, Li J, Ahmed RA, Wong NC, Ishida T.

Gut. 2008 May;57(5):664-71. Epub 2007 Nov 12.

PMID:
17998316
13.

Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.

Alvarado Esquivel C, Elewaut A, Philippé J, Elewaut AE, Desombere I, Maertens G, Leroux-Roels G.

Rev Invest Clin. 2002 Jan-Feb;54(1):41-50.

PMID:
11995406
14.

Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to Interferon alpha.

Li J, Chen F, Zheng M, Zhu H, Zhao D, Liu W, Liu W, Chen Z.

Antiviral Res. 2010 Mar;85(3):463-9. doi: 10.1016/j.antiviral.2009.10.011. Epub 2009 Oct 24.

PMID:
19857525
15.

Interferon alfa down-regulates CD81 in patients with chronic hepatitis C.

Kronenberger B, Rüster B, Elez R, Weber S, Piiper A, Lee JH, Roth WK, Zeuzem S.

Hepatology. 2001 Jun;33(6):1518-26.

PMID:
11391542
16.

Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.

Zografos TA, Liaskos C, Rigopoulou EI, Togousidis E, Makaritsis K, Germenis A, Dalekos GN.

Am J Gastroenterol. 2008 Mar;103(3):605-14. doi: 10.1111/j.1572-0241.2007.01729.x. Epub 2008 Jan 8.

PMID:
18190648
17.

Effects of interferon plus ribavirin treatment on NF-kappaB, TGF-beta1, and metalloproteinase activity in chronic hepatitis C.

Guido M, De Franceschi L, Olivari N, Leandro G, Felder M, Corrocher R, Rugge M, Pasino M, Lanza C, Capelli P, Fattovich G.

Mod Pathol. 2006 Aug;19(8):1047-54. Epub 2006 May 12.

18.

Cyclooxygenase-2 expression in chronic hepatitis C and the effect of interferon alpha treatment.

Manning DS, Sheehan KM, Byrne MF, Kay EW, Murray FE.

J Gastroenterol Hepatol. 2007 Oct;22(10):1633-7.

PMID:
17845691
20.

Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.

Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C.

Hepatology. 2003 May;37(5):1180-8.

PMID:
12717400

Supplemental Content

Support Center